Phase 1 SARS-CoV-2 infection Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
SARS-CoV-2 infection
Children's National Research Institute24 enrolled2 locationsNCT05141058
Recruiting
Phase 1Phase 2
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
SARS-CoV-2 infectionCOVID-19
Kara Chew80 enrolled2 locationsNCT06810934
Not Yet Recruiting
Phase 1
To Evaluate the Safety, Tolerability, and Immunogenicity of a PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Healthy Individuals
COVID 19 or SARS-CoV-2 Infection
Yisheng Biopharma (Singapore) Pte Ltd45 enrolled1 locationACTRN12621001009808